About Us
Overview
Our Business
Board of Directors
Executive Leadership Team
Our Stories
Biocon Biologics Malaysia
Scientific Publications
Awards & Recognition
Our Legacy
Business
Global Biosimilars Portfolio
Oncology
Immunology
Diabetology
Ophthalmology
Bone Health & Others
Our Products
Global
India
Partners
Global Footprint
Capabilities
Research & Development
Quality & Compliance
Global Scale Manufacturing
Commitment
Investors
News
Press Releases
Company Statements
Our Stories
Media Contacts
Careers
Working With Us
Now Hiring
Contact Us
Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility
Fri, 05-Aug-2022
Posted by: Biocon Biologics
No Comments
Biocon Q1FY23 Revenue at Rs 2,217 Cr, Up 23%; Net Profit at Rs 144 Cr, Up 71%; Core EBITDA at Rs 660 Cr Up 25%
Wed, 27-Jul-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru
Tue, 05-Jul-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics issues a statement in response to the media reports related to bribery allegations
Tue, 21-Jun-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics Denies Bribery Allegations
Tue, 21-Jun-2022
Posted by: Biocon Biologics
No Comments
University of Glasgow officially Opens Mazumdar-Shaw Advance Research Centre
Thu, 09-Jun-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics and Viatris Launch Abevmy® (bBevacizumab), Their Third Oncology Biosimilar, in Canada
Thu, 19-May-2022
Posted by: Biocon Biologics
No Comments
Biocon Q4FY22 Revenue at Rs 2,476 Cr, Up 21%; Core EBITDA at Rs 815 Cr, Up 37% ; PBT(before Exceptional Items) at Rs 384 Cr, Up 9%
Thu, 28-Apr-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics’ Insugen® Awarded a Three-Year Contract by Ministry of Health, Malaysia
Tue, 26-Apr-2022
Posted by: Biocon Biologics
No Comments
Biocon Biologics’ Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion
Fri, 01-Apr-2022
Posted by: Biocon Biologics
No Comments
1
2
3
4
…
19